Searched for
PHARMACEUTICAL DEBT REFINANCING
Sun Pharma looks to outshine rival bids with $13 billion Organon offerSun Pharmaceutical is making its biggest move yet with a $13 billion offer for Organon & Co. This ambitious bid aims to transform the India...- Vivriti Asset Management plans Rs 5,000-cr diversified bond fundVivriti Asset Management plans to launch a diversified bond fund of ₹5,000 crore in the second quarter of the next financial year, with a g...
- Large HNI and institutional money continuing to buy on every dip: N JayakumarN Jayakumar of Prime Securities believes India is attracting substantial investment due to its strong foundation. He estimates significant ...
- India resurgence fund in talks to acquire Ind-Swift's API businessEarlier in July 2021, Ind-Swift Laboratories had agreed to sell its API business to PI Industries on a slump sale basis, for ₹1,530 crore. ...
- 10 tips for D-Street investors if the interest rate regime remains stableAnother expert, Deepak Jasani, Head of Retail Research at HDFC Securities, said the RBI would take a call on rates going forward based on v...
- Almost half of rated Indian cos get profitability boost from weak rupee: S&P“Much of our rated India corporate portfolio has sizable US-dollar linked revenue and, therefore, is not exposed to rupee depreciation…Abou...
- Tata Power raising $320m in sustainability-linked loansBoth the loans are in dollar denomination with a tenor of about three years. They will be priced after adding 125-150 basis points over the...
- Stocks in the news: L&T, Sun Pharma, PNB, Zomato, Bank of India and RECOnline food delivery service provider Zomato plans to deliver food to its customers in record 10 minutes, following the footsteps of grocer...
- Novelis refinance costs dent Hindalco Q4 profitCompany reports 43% drop in consolidated profit, optimistic about U-shaped recovery.
- Glenmark Q3 profit zooms 64% to Rs 191 crore; firm to raise $400 millionRevenue stood at Rs 2,735.56 crore against Rs 2,555.04 crore last year.
- Stocks in the news: Infosys, YES Bank, D-Mart, Edelweiss Financial and Snowman LogisticsDrug firm Granules India is recalling over 2.3 crore ranitidine tablets.
- Buyout giants in talks with Wockhardt for domestic formulations businessThe individual suitors have indicated that they are interested in buying at least 51% stake in a deal that could value the biz at Rs 4,000-...
- Wockhardt hires bankers for raising $300 million via dollar bondDue to a severe cash crunch, Wockhardt is facing a refinancing risk in FY19.
- Teva shows the flip side of rapidly growing corporate leverageTeva slashed its earnings goals for a second time this year and cut its dividend, too.
- After a profit warning, Sun Pharma seeks to tap global debt market to raise $1 billion“The size of the bond issuance is expected to be in the range of $500-1,000 million with five- to 10-year maturities, depending on its pric...
- BSE 500: Tata Motors, M&M, Marico, Tata Global, Titan and Havells India imrpove debt to equity ratioIndustry trackers say that the trend will largely be sector dependent in next few years with construction, infra, and realty cos under far ...
- Investments in expanding Taro research top priority: Sun PharmaInvestments in expanding Taro's research and capacity expansion in India will be Sun Pharma's top agenda for the upcoming year, Dilip Shang...
- Khorakiwala quits as MD amid Wockhardt debt pileMumbai-based pharma major Wockhardt on Tuesday announced a major organisational change and admitted that it was facing problems in servicin...
- Sun Pharma to buy Taro for $454 mnSecond-largest overseas buyout by an Indian pharma company will give Sun an edge in North America where Israeli generics player records 90%...
- India Inc may see fall in credit profiles: ICRAIn a bid to keep pace with rising investment demand fuelled by bank credit and higher funding requirements, Indian corporations may face de...
Load More
